دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
AI in medicine: creating a safe and equitable future
doi : 10.1016/S0140-6736(23)01668-9
Volume 402, Issue 10401, 12–18 August 2023, Page 503
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
*Stephen C Bain, Thinzar Min
doi : 10.1016/S0140-6736(23)01182-0
Volume 402, Issue 10401, 12–18 August 2023, Pages 504-505
Transcranial direct current stimulation as a treatment for major depressive disorder
Daphne Voineskos, *Daniel M Blumberger
doi : 10.1016/S0140-6736(23)00822-X
Volume 402, Issue 10401, 12–18 August 2023, Pages 506-507
Janus kinase inhibition in juvenile idiopathic arthritis
Eileen C Rife, *Randy Q Cron
doi : 10.1016/S0140-6736(23)01134-0
Volume 402, Issue 10401, 12–18 August 2023, Pages 508-509
The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery
Katherine L O’Brien, Ephrem Lemango
doi : 10.1016/S0140-6736(23)01468-X
Volume 402, Issue 10401, 12–18 August 2023, Pages 510-512
Rising tide: opportunities for accelerating action on drowning prevention
*Jagnoor Jagnoor, Justin-Paul Scarr
doi : 10.1016/S0140-6736(23)01463-0
Volume 402, Issue 10401, 12–18 August 2023, Pages 512-514
Syphilis rates soar in the USA amid penicillin shortage
Roxanne Nelson
doi : 10.1016/S0140-6736(23)01665-3
Volume 402, Issue 10401, 12–18 August 2023, Page 515
UK aid cuts will lead to thousands of deaths
Sharmila Devi
doi : 10.1016/S0140-6736(23)01666-5
Volume 402, Issue 10401, 12–18 August 2023, Page 516
Tech companies criticise health AI regulations
Paul Webster
doi : 10.1016/S0140-6736(23)01667-7
Volume 402, Issue 10401, 12–18 August 2023, Pages 517-518
Vanessa Kerry: driving action on climate change and health
Udani Samarasekera
doi : 10.1016/S0140-6736(23)01628-8
Volume 402, Issue 10401, 12–18 August 2023, Page 519
Are we training our students to be white saviours in global health?
*Ananya Tina Banerjee, Shashika Bandara, Joyeuse Senga, Nadia Gonz?lez-Dom?nguez, Madhukar Pai
doi : 10.1016/S0140-6736(23)01629-X
Volume 402, Issue 10401, 12–18 August 2023, Pages 520-521
Evelyn Ruth Maisel Witkin
Geoff Watts
doi : 10.1016/S0140-6736(23)01630-6
Volume 402, Issue 10401, 12–18 August 2023, Page 522
Author gender representation of journal reviews and editorials on lymphoma (2017–22)
Eliza A Hawkes, Judith Trotman, Carla Casulo, Sonali M Smith, Ann LaCasce, on behalf of the international Women in Lymphoma Steering Committee
doi : 10.1016/S0140-6736(23)01428-9
Volume 402, Issue 10401, 12–18 August 2023, Pages 523-525
A need for safe infant feeding in low-resource health-care facilities
Maya L Nadimpalli, Bethany Caruso, Melissa F Young, Sheela S Sinharoy
doi : 10.1016/S0140-6736(23)01197-2
Volume 402, Issue 10401, 12–18 August 2023, Pages 525-526
mRNA vaccines do not stop with COVID-19
Jin Zhou, Yu Zhang, Ke Mo, Herbert Newbert, *Xicheng Song
doi : 10.1016/S0140-6736(23)01514-3
Volume 402, Issue 10401, 12–18 August 2023, Page 526
Misclassification of overdose events in the X:BOT study
Nabarun Dasgupta, Elizabeth M Ajazi, Todd A Schwartz, Stephen W Marshall
Misclassification of overdose events in the X:BOT study – Authors' reply
Joshua D Lee, Edward V Nunes, Paul Van Veldhuisen, Robert Lindblad, John Rotrosen
doi : 10.1016/S0140-6736(23)00049-1
Volume 402, Issue 10401, 12–18 August 2023, Pages 527-528
Department of Error
doi : 10.1016/S0140-6736(23)01631-8
Volume 402, Issue 10401, 12–18 August 2023, Page 528
Department of Error
doi : 10.1016/S0140-6736(23)01632-X
Volume 402, Issue 10401, 12–18 August 2023, Page 528
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Julio Rosenstock, Juan Frias, Ania M Jastreboff, Yu Du, Jitong Lou, Sirel Gurbuz, Melissa K Thomas, Mark L Hartman, Axel Haupt, Zvonko Milicevic, Tamer Coskun
doi : 10.1016/S0140-6736(23)01053-X
Volume 402, Issue 10401, 12–18 August 2023, Pages 529-544
Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial
Gerrit Burkhardt, Ulrike Kumpf, Alexander Crispin, Stephan Goerigk, Elisabeth Andre, Christian Plewnia, Bettina Brendel, Andreas Fallgatter, Berthold Langguth, Mohamed Abdelnaim, Tobias Hebel, Claus Normann, Lukas Frase, Peter Zwanzger, Julia Diemer, Thomas Kammer, Carlos Sch?nfeldt- Lecuona, Daniel Kamp, Malek Bajbouj, Nora Behler, Anja Wilkening, Tabea Nenov-Matt, Esther Dechantsreiter, Daniel Keeser, Lucia Bulubas, Ulrich Palm, Christiane Blankenstein, Ulrich Mansmann, Peter Falkai, Andre R Brunoni, Alkomiet Hasan, Frank Padberg
doi : 10.1016/S0140-6736(23)00640-2
Volume 402, Issue 10401, 12–18 August 2023, Pages 545-554
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
Athimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, Ivan Foeldvari, Alberto Spindler, ??rka Fingerhutov?, Jordi Ant?n, Zhongkai Wang, Gabriella Meszaros, Joana Ara?jo, Ran Liao, Stuart Keller, Hermine I Brunner, Nicolino Ruperto, on behalf of the JUVE-BASIS investigators* and the Paediatric Rheumatology International Trials Organisation
doi : 10.1016/S0140-6736(23)00921-2
Volume 402, Issue 10401, 12–18 August 2023, Pages 555-570
Venous insufficiency and acrocyanosis in long COVID: dysautonomia
Nafi Iftekhar, Manoj Sivan
doi : 10.1016/S0140-6736(23)01461-7
Volume 402, Issue 10401, 12–18 August 2023, Page e9
Ulcerative colitis
Catherine Le Berre, Sailish Honap, Laurent Peyrin-Biroulet
doi : 10.1016/S0140-6736(23)00966-2
Volume 402, Issue 10401, 12–18 August 2023, Pages 571-584
